Detection of Multi-Drug Resistant Tuberculosis Using the Genotype MTBDR DNA Strip Assay and Lowenstein Jensen Proportion Method
Bosede Oyewumi Amuda, O. O. Oduyebo, Philip Abutu
Asian Journal of Research in Infectious Diseases · pp. 11–22 · Published 25 Jun 2020
10.9734/ajrid/2020/v4i230142Abstract
Pulmonary tuberculosis (TB) remains a significant public health issue in low-middle income countries. Accurate and timely diagnosis is key to effective management. Diagnosing Multi Drug Resistance Tuberculosis (MDR-TB) is mostly done with phenotypic Lowenstein Jenson (LJ) proportion method with long turn around which delays treatment. The genotypic MTBDR plus was introduced by World Health Organisation (W.H.O) for the same purpose hence, this study aims to detect MDR-TB using both two methods. Sputum samples were collected from cases of pulmonary TB diagnosed with Genexpert and Ziehl Neelsen stain. Positive samples were subjected to MTBDR plus and the LJ proportion method with the LJ method considered gold standard. Chi square analysis was used to evaluate the Sensitivity, Specificity, Positive Predictive value (PPV), Negative Predictive value (NPV), of the MTBDR plus method compared to the LJ Proportion method. Kappa values were also estimated as a measure of agreement between the two methods. In evaluating the performance of MTBDR plus compared to the LJ proportion method, the sensitivity, specificity, PPV and NPV for the detection of rifampicin and isoniazid was 93.7%, 90.2%, 92.5% ,91.7% and 88.5%, 95.5%,92.0% and 93.3% respectively, while evaluation MDR-TB was 74.5%, 94.4%, 88.4% and 86.6% with a Kappa value of 0.85,0.84 and 0.71 for Isoniazid, Rifampicin and MDR-TB which indicate almost perfect agreement for both rifampicin and isoniazid and substantial agreement for Multi Drug Resistance (MDR). Compared to LJ proportion method, MTBDRplus performed well in the detection of drug resistance to rifampicin, isoniazid and MDR-TB, hence, is a rapid and efficient tool for the diagnosis and initiation of treatment for MDR-TB.
Cited by 2
Palmi Modi, Shivani Patel, Mahesh Chhabria · Molecular Diversity · 2022
Xin Mao, Jingkai Wang, Junchi Xu · Journal of Applied Microbiology · 2025
Related research
- Clinical Characteristics and Outcome Predictors in Drug-Resistant Tuberculosis: A Comprehensive Analysis — shares topic coverage
- Has the Pandemic Triggered a ‘Paperdemic’? Towards an Assessment of Diagnostic Indicators for COVID-19 — shares topic coverage
- Checking Consistency among the Four Basic Indicators of Diagnostic Testing in Saudi Medical Journals — shares topic coverage
- Measures, Metrics, and Indicators Derived from the Ubiquitous Two-by-Two Contingency Table, Part B: Examples — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.